Difference between revisions of "Key molecular pathways in ALS"

From MyWiki
Jump to: navigation, search
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
 +
{{tip|For very comprehensive pathway diagrams for LMN ALS see, https://files.acrobat.com/a/preview/646bf152-9ef2-4f51-8d4a-cb8e9fc0a4ac}}
 +
 
{| class="wikitable"
 
{| class="wikitable"
 
! Pathway || Type || Activated by || Inhibited by || Activates || Inhibits
 
! Pathway || Type || Activated by || Inhibited by || Activates || Inhibits
Line 17: Line 19:
 
|-
 
|-
 
| VEGF
 
| VEGF
+
 
For very comprehensive pathway diagrams for LMN ALS see, https://files.acrobat.com/a/preview/646bf152-9ef2-4f51-8d4a-cb8e9fc0a4ac
 
 
|}
 
|}

Latest revision as of 09:46, 28 February 2018

For very comprehensive pathway diagrams for LMN ALS see, https://files.acrobat.com/a/preview/646bf152-9ef2-4f51-8d4a-cb8e9fc0a4ac
Pathway Type Activated by Inhibited by Activates Inhibits
NF-kappaB Inflammatory
TNF-alpha
caspase-3
AMPK-α1
IL-10
SARM1
PKC
VEGF